Phathom Pharmaceuticals Announces Proposed Public Offering Of Common Stock; No Size Or Amount Disclosed
Portfolio Pulse from Benzinga Newsdesk
Phathom Pharmaceuticals announces a proposed public offering of an additional 15% of its common stock, potentially diluting existing shareholders' stakes.
May 23, 2023 | 8:03 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Phathom Pharmaceuticals' proposed public offering of an additional 15% of common stock may lead to stock dilution for existing shareholders.
Phathom Pharmaceuticals' announcement of a proposed public offering of an additional 15% of its common stock may have a negative short-term impact on its stock price. The offering could lead to stock dilution for existing shareholders, as their percentage ownership in the company will decrease. This may result in a decrease in the stock's value in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100